Will Late Loss Debate Stifle Device Start-Up Innovation?
The failure of Medtronic's Endeavor stent to hit its primary clinical trial goals has again spurred debate over surrogate endpoints, a poetntially big issue for small companies.
The failure of Medtronic's Endeavor stent to hit its primary clinical trial goals has again spurred debate over surrogate endpoints, a poetntially big issue for small companies.